Jamteki 45 mg (Ustekinumab SOLUTION) 45 MG

JAMTEKI 45 MG is a subcutaneous solution containing ustekinumab, used for managing moderate to severe conditions. This biologic therapy is designed to target specific immune responses, offering a tailored approach to treatment.

Strength

45 MG

Manufacturer / TM Owner

JAMP PHARMA CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

JAMTEKI 45 MG is primarily used for the treatment of moderate to severe plaque psoriasis and other immune-mediated conditions. It works by targeting specific proteins in the immune system to reduce inflammation and symptoms. Patients often seek ustekinumab for its potential to manage chronic skin conditions effectively.

Side Effects

Common effects of JAMTEKI 45 MG may include injection site reactions, such as redness or swelling. Some users also report fatigue or mild headaches. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

JAMTEKI 45 MG should be handled with care, ensuring proper storage and administration. It is important to follow healthcare provider instructions for subcutaneous use. Patients with a history of infections or allergies should discuss this with their healthcare provider before starting treatment.

Avoid Interactions

JAMTEKI 45 MG may interact with other medications, including those that affect the immune system. It is advisable to inform your healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions.

Frequently Asked Questions

JAMTEKI 45 MG is used for managing moderate to severe plaque psoriasis and other immune-mediated conditions.

JAMTEKI 45 MG is administered subcutaneously, typically by injection.

Common effects may include injection site reactions, fatigue, and mild headaches.

It is important to consult a healthcare provider before combining JAMTEKI 45 MG with other medications.

Patients with a history of severe infections or allergies should discuss use with their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.